Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
A Prospective Study on Online Adaptive Radiotherapy (ART) Using the ETHOS Linear Accelerator for Various Tumor Entities and the Feasibility of Integrating Multi-Parametric Patient Data Into the Adaptive Workflow
Charite University, Berlin, Germany
649 participants
Oct 11, 2023
OBSERVATIONAL
Conditions
Summary
The study focuses on the scientific and clinical evaluation of online adaptive radiotherapy (ART) using the Varian/SHS ETHOS treatment system. In this study, radiation treatment plans are dynamically adjusted on a daily basis over several weeks of therapy to account for anatomical shifts in either the tumour or adjacent normal tissue - a capability that has been difficult to achieve due to technical limitations. With the ETHOS accelerator, such real-time adjustments can be made based on cone beam computed tomography (CBCT). This is a prospective observational study with the primary objective of investigating the feasibility and acceptability of performing ART with ETHOS for different tumour entities. The study will also evaluate the feasibility of integrating multi-parametric data sets into the ART workflow, such as standardised electronic feedback on treatment toxicity from both patients (ePROMS) and physicians (ePRT).
Eligibility
Inclusion Criteria3
- Adult patients (\>18 years)
- All tumor entities with an indication for radiotherapy and/or chemoradiotherapy
- Signed informed consent
Exclusion Criteria2
- Pregnancy
- Patients who are not capable of giving consent
Interventions
Daily cone-beam CT based online adaptive radiation therapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06116019